Skip to main content
Top
Literature
12.
go back to reference Kim JC, Park EY, Seo SI, Park YH, Hwang TK (2006) Nerve growth factor and prostaglandins in the urine of female patients with overactive bladder. J Urol 175(5):1773–1776PubMedCrossRef Kim JC, Park EY, Seo SI, Park YH, Hwang TK (2006) Nerve growth factor and prostaglandins in the urine of female patients with overactive bladder. J Urol 175(5):1773–1776PubMedCrossRef
13.
go back to reference Liu HT, Chancellor MB, Kuo HC (2009) Decrease of urinary nerve growth factor levels after antimuscarinic therapy in patients with overactive bladder. BJU Int 103(12):1668–1672PubMedCrossRef Liu HT, Chancellor MB, Kuo HC (2009) Decrease of urinary nerve growth factor levels after antimuscarinic therapy in patients with overactive bladder. BJU Int 103(12):1668–1672PubMedCrossRef
14.
go back to reference Liu HT, Lin H, Kuo HC (2011) Increased serum nerve growth factor levels in patients with overactive bladder syndrome refractory to antimuscarinic therapy. Neurourol Urodyn 30(8):1525–1529PubMedCrossRef Liu HT, Lin H, Kuo HC (2011) Increased serum nerve growth factor levels in patients with overactive bladder syndrome refractory to antimuscarinic therapy. Neurourol Urodyn 30(8):1525–1529PubMedCrossRef
15.
go back to reference Liu HT, Chancellor MB, Kuo HC (2009) Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection. Eur Urol 56(4):700–706PubMedCrossRef Liu HT, Chancellor MB, Kuo HC (2009) Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection. Eur Urol 56(4):700–706PubMedCrossRef
21.
go back to reference Pinto R, Lopes T, Frias B, Silva A, Silva JA, Silva CM et al (2010) Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome/interstitial cystitis. Eur Urol Sep 58(3):360–365CrossRef Pinto R, Lopes T, Frias B, Silva A, Silva JA, Silva CM et al (2010) Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome/interstitial cystitis. Eur Urol Sep 58(3):360–365CrossRef
22.
go back to reference Antunes-Lopes T, Pinto R, Carvalho-Barros S, Diniz P, Martins-Silva C et al (2012) Urinary levels of brain derived neurotrophic factor (BDNF) in women with overactive bladder (OAB) syndrome correlate with the severity of symptoms. Eur Urol Suppl 10(2):277–278CrossRef Antunes-Lopes T, Pinto R, Carvalho-Barros S, Diniz P, Martins-Silva C et al (2012) Urinary levels of brain derived neurotrophic factor (BDNF) in women with overactive bladder (OAB) syndrome correlate with the severity of symptoms. Eur Urol Suppl 10(2):277–278CrossRef
26.
go back to reference Liu HT, Tyagi P, Chancellor MB, Kuo HC (2010) Urinary nerve growth factor but not prostaglandin E2 increases in patients with interstitial cystitis/bladder pain syndrome and detrusor overactivity. BJU Int 106(11):1681–1685PubMedCrossRef Liu HT, Tyagi P, Chancellor MB, Kuo HC (2010) Urinary nerve growth factor but not prostaglandin E2 increases in patients with interstitial cystitis/bladder pain syndrome and detrusor overactivity. BJU Int 106(11):1681–1685PubMedCrossRef
27.
go back to reference Tyagi P, Barclay D, Zamora R, Yoshimura N, Peters K, Vodovotz Y et al (2010) Urine cytokines suggest an inflammatory response in the overactive bladder: a pilot study. Int Urol Nephrol 42(3):629–635PubMedCrossRef Tyagi P, Barclay D, Zamora R, Yoshimura N, Peters K, Vodovotz Y et al (2010) Urine cytokines suggest an inflammatory response in the overactive bladder: a pilot study. Int Urol Nephrol 42(3):629–635PubMedCrossRef
28.
go back to reference Ghoniem G, Faruqui N, Elmissiry M, Mahdy A, Abdelwahab H, Oommen M et al (2011) Differential profile analysis of urinary cytokines in patients with overactive bladder. Int Urogynecol J 22(8):953–961PubMedCrossRef Ghoniem G, Faruqui N, Elmissiry M, Mahdy A, Abdelwahab H, Oommen M et al (2011) Differential profile analysis of urinary cytokines in patients with overactive bladder. Int Urogynecol J 22(8):953–961PubMedCrossRef
32.
go back to reference Chuang YC, Tyagi V, Liu RT, Chancellor MB, Tyagi P (2010) Urine and serum C-reactive protein levels as potential biomarkers of lower urinary tract symptoms. Urol Sci 21(3):132–136CrossRef Chuang YC, Tyagi V, Liu RT, Chancellor MB, Tyagi P (2010) Urine and serum C-reactive protein levels as potential biomarkers of lower urinary tract symptoms. Urol Sci 21(3):132–136CrossRef
33.
go back to reference Chung SD, Liu HT, Lin H, Kuo HC (2011) Elevation of serum c-reactive protein in patients with OAB and IC/BPS implies chronic inflammation in the urinary bladder. Neurourol Urodyn 30(3):417–420PubMedCrossRef Chung SD, Liu HT, Lin H, Kuo HC (2011) Elevation of serum c-reactive protein in patients with OAB and IC/BPS implies chronic inflammation in the urinary bladder. Neurourol Urodyn 30(3):417–420PubMedCrossRef
34.
go back to reference Kupelian V, McVary KT, Barry MJ, Link CL, Rosen RC, Aiyer LP et al (2009) Association of C-reactive protein and lower urinary tract symptoms in men and women: results from Boston Area Community Health survey. Urology 73(5):950–957PubMedCrossRef Kupelian V, McVary KT, Barry MJ, Link CL, Rosen RC, Aiyer LP et al (2009) Association of C-reactive protein and lower urinary tract symptoms in men and women: results from Boston Area Community Health survey. Urology 73(5):950–957PubMedCrossRef
Metadata
Title
Erratum to: Biomarkers in overactive bladder
Authors
Alka A. Bhide
Rufus Cartwright
Vik Khullar
G. Alessandro Digesu
Publication date
01-10-2013
Publisher
Springer London
Published in
International Urogynecology Journal / Issue 10/2013
Print ISSN: 0937-3462
Electronic ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-013-2198-4

Other articles of this Issue 10/2013

International Urogynecology Journal 10/2013 Go to the issue